Recent Advances in Superhydrophobic Materials Development for Maritime Applications.

Underwater superhydrophobic surfaces stand as a promising frontier in materials science, holding immense potential for applications in underwater infrastructure, vehicles, pipelines, robots, and sensors. Despite this potential, widespread commercial adoption of these surfaces faces limitations, primarily rooted in challenges related to material durability and the stability of the air plastron during prolonged submersion. Factors such as pressure, flow, and temperature further complicate the operational viability of underwater superhydrophobic technology. This comprehensive review navigates the evolving landscape of underwater superhydrophobic technology, providing a deep dive into the introduction, advancements, and innovations in design, fabrication, and testing techniques. Recent breakthroughs in nanotechnology, magnetic-responsive coatings, additive manufacturing, and machine learning are highlighted, showcasing the diverse avenues of progress. Notable research endeavors concentrate on enhancing the longevity of plastrons, the fundamental element governing superhydrophobic behavior. The review explores the multifaceted applications of superhydrophobic coatings in the underwater environment, encompassing areas such as drag reduction, anti-biofouling, and corrosion resistance. A critical examination of commercial offerings in the superhydrophobic coating landscape offers a current perspective on available solutions. In conclusion, the review provides valuable insights and forward-looking recommendations to propel the field of underwater superhydrophobicity toward new dimensions of innovation and practical utility.

Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription.

The chromatin remodeling gene AT-rich interactive domain-containing protein 1A (ARID1A) encodes the protein BAF250a, a subunit of human SWI/SNF-related complexes. Recent studies have identified ARID1A as a tumor suppressor. Here, we show that ARID1A expression is reduced in gastric cancer (GC) tissues, which are significantly associated with local lymph node metastasis, tumor infiltration and poor patient prognosis. ARID1A silencing enforces the migration and invasion of GC cells, whereas ectopic expression of ARID1A inhibits migration. The adhesive protein E-cadherin is remarkably downregulated in response to ARID1A silencing, but it is upregulated by ARID1A overexpression. E-cadherin overexpression significantly inhibits GC cell migration and invasion, whereas CDH1 (coded E-cadherin) silencing promotes migration. Restored expression of CDH1 in ARID1A-silenced cell lines restores the inhibition of cell migration. Luciferase reporter assays and chromatin immunoprecipitation indicate that the ARID1A-associated SWI/SNF complex binds to the CDH1 promoter and modulates CDH1 transcription. ARID1A knockdown induces evident morphological changes of GC cells with increased expression of mesenchymal markers, indicating an epithelial-mesenchymal transition. ARID1A silencing does not alter the level of ß-catenin but induces a subcellular redistribution of ß-catenin from the plasma membrane to the cytoplasm and nucleus. Immunohistochemical studies demonstrate that reduced expression of E-cadherin is associated with local lymph node metastasis, tumor infiltration and poor clinical prognosis. ARID1A and E-cadherin expression show a strong correlation in 75.4% of the analyzed GC tissues. They are synergistically downregulated in 23.5% of analyzed GC tissues. In conclusion, ARID1A targets E-cadherin during the modulation of GC cell migration and invasion.

[Evaluation the value of number of metastatic perigastric lymph nodes on prognosis in patients with gastric cancer].

OBJECTIVE: To find out a simple and reproductive prognostic index in gastric cancer patients,which can be used as a comparable parameter among different regions of China. METHODS: The perigastric metastatic lymph nodes(PGMLN) with long-term survival data were retrospectively evaluated in 148 gastric cancer patients, undergone potentially curative resections. RESULTS: The 3-year cumulative survival rate was 62.8% and the survival rate decreased significantly with the increase of PGMLN, especially when the PGMLN was more than 6. The PGMLN had a clear linear relationship with total positive lymph nodes(r=0.94, P<0.01), while it had little correlation with total resected lymph nodes(r=0.18,P=0.2). CONCLUSIONS: PGMLN is a convenient and reliable prognostic factor in gastric cancer patients, which may be a good candidate of comparable parameters among different regions of China.